Physician profile
Michael Leininger
NPI 1235147257
$1,841.64
in general payments reported to CMS, 2019-2025
14 companies · $1,309 in 2025
The $1,309 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.13 · 2022: $99.98 · 2023: $57.76 · 2024: $288 · 2025: $1,309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,032 · Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,031.50 |
| Food and Beverage | $623.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Cardiovascular Systems Corporation | $1,209.30 | 2025 | Virtuosaph Plus With Radial Indication, Herc Flex Universal Stabilizer Arm |
| Atricure, INC. | $141.80 | 2024 | |
| Ethicon US, LLC | $126.32 | 2024 | Surgiflo Hemostatic Matrix, Ethicon, Prolene |
| Innovative Medical Devices, INC. | $73.40 | 2025 | |
| Terumo Medical Corporation | $68.16 | 2021-2022 | |
| Lemaitre Vascular, INC. | $47.89 | 2022-2024 | Trivex System, Restoreflow |
| Edwards Lifesciences Corporation | $41.50 | 2023 | Inspiris Resilia Aortic Valve |
| Medtronic, INC. | $35.04 | 2022 | |
| Lsi Solutions INC | $24.41 | 2022 | |
| Boston Scientific Corporation | $21.91 | 2021 | |
| W. L. Gore & Associates, INC. | $13.90 | 2021 | |
| Chiesi USA, INC. | $13.51 | 2025 | Kengreal, Cleviprex |
| Elutia, INC. | $12.83 | 2025 | Ecm Patch,Pouch |
| Astrazeneca Pharmaceuticals LP | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Leininger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.